MCMCB Pro
J3399

J3399Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes

HCPCSActiveBETOS O1E

J3399 is a HCPCS Level II code for injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J3399 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
1 unit
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
1 unit
MAI 3 — Date of Service Edit: Clinical · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J3399

Long descriptor
Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes

The official wording. This is what the code means.

Short descriptor
Inj onase abepar-xioi treat

CMS's 28-character form, which is what shows up on a remittance advice.

Added
July 1, 2020

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J3399

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J3399 is not quite right, the correct code is very often within a few positions of it.

  • J3389Topical administration, prademagene zamikeracel, per treatment
  • J3391Injection, atidarsagene autotemcel, per treatment
  • J3392Injection, exagamglogene autotemcel, per treatment
  • J3393Injection, betibeglogene autotemcel, per treatment
  • J3394Injection, lovotibeglogene autotemcel, per treatment
  • J3396Injection, verteporfin, 0.1 mg
  • J3397Injection, vestronidase alfa-vjbk, 1 mg
  • J3398Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
  • J3400Injection, triflupromazine hcl, up to 20 mgterminated
  • J3401Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
  • J3402Injection, remestemcel-l-rknd, per therapeutic dose
  • J3403Revakinagene taroretcel-lwey, per implant
  • J3404Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
  • J3405Injection, onasemnogene abeparvovec-brve, per treatment
  • J3410Injection, hydroxyzine hcl, up to 25 mg
  • J3411Injection, thiamine hcl, 100 mg

Questions about J3399

What is HCPCS code J3399?

J3399 is a HCPCS Level II code for injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J3399?

The CMS HCPCS file marks J3399 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J3399 paid under the physician fee schedule?

J3399 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026